Everett E. Vokes

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

(2023)10.1158/1078-0432.c.6532910.v1

Top 100%

0DataRank

Top 100%0 citations

D. Neil Hayes, Theodore Karrison, Olivier Harismendy, José M. Flores, Tara Moore‐Medlin +17 more

Papers

Driven by 29 papers — median percentile 0. Top paper: “Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer”.

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2212083

N/A

7.7DataRank · unranked

1042 citations

Xiaofei Wang, David Kozono, Colleen Watt, Rodney Landrenau, Dennis A. Wigle +16 more

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

New England Journal of Medicine(2015)10.1056/nejmoa1507643

N/A

1.4DataRank · unranked

9414 citations

Luis Paz-Ares, Diane P Holder, David R. Spigel, Martin Steins, Neal E. Ready +38 more

Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment

BMC Cancer(2022)10.1186/s12885-021-09146-z

N/A

0.654DataRank · unranked

18 citations

Evgeny Izumchenko, Alexander T. Pearson, Zhen Gooi, Elizabeth A. Blair, Theodore Karrison +14 more

Using a Clinically Interpretable End Point Composed of Multiple Outcomes to Evaluate Totality of Treatment Effect in Comparative Oncology Studies

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.19055

N/A

0.104DataRank · unranked

1 citations

Zachary R. McCaw, Lü Tian, Thomas E. Stinchcombe, Everett E. Vokes, Ethan B. Ludmir +2 more

Dose and volume de-escalation for HPV-associated oropharyngeal cancer: Long-term follow-up of the OPTIMA trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6575

N/A

0DataRank · unranked

2 citations

Nishant Agrawal, Alexander T. Pearson, Tanguy Y. Seiwert, Zhen Gooi, Elizabeth A. Blair +9 more

Lung-MAP (SWOG S1400): Design, implementation, and lessons learned from a biomarker-driven master protocol (BDMP) for previously-treated squamous lung cancer (sqNSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9576

N/A

0DataRank · unranked

2 citations

Vassiliki A. Papadimitrakopoulou, Katherine Minichiello, David R. Gandara, Fred R. Hirsch, Philip C. Mack +14 more

Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups

UNC Libraries(2020)10.17615/6qqs-re95

N/A

0DataRank · unranked

0 citations

Xiaofei Wang, Daniel J. Sargent, William G. Richards, Everett E. Vokes, Herbert Pang +6 more

Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity

Science Translational Medicine(2021)10.1126/scitranslmed.abb0130

N/A

0DataRank · unranked

95 citations

Hua Liang, Xinshuang Yu, Zhida Liu, Xuezhi Cao, Enyu Rao +17 more

All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages

Science Immunology(2021)10.1126/sciimmunol.aba8426

N/A

0DataRank · unranked

53 citations

Yuzhu Hou, Xiaona Huang, Liangliang Wang, Jiaai Wang, Wenxin Zheng +10 more

Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience

Oral Oncology(2021)10.1016/j.oraloncology.2021.105566

N/A

0DataRank · unranked

31 citations

Nishant Agrawal, Alexander T. Pearson, Zhen Gooi, Elizabeth A. Blair, John Cursio +13 more

Evaluation of Oncology Trial Results Reporting Over a 10-Year Period

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.10438

N/A

0DataRank · unranked

24 citations

Yuan Zhang, Wen‐Fei Li, Everett E. Vokes, Ying Sun, Quynh‐Thu Le +2 more

Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8505

N/A

0DataRank · unranked

37 citations

Xiaofei F. Wang, Gregory A. Masters, Junheng Gao, Ritsuko Komaki, Charles Kuzma +8 more

Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology

Nature Communications(2022)10.1038/s41467-022-34025-x

N/A

0DataRank · unranked

125 citations

Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Brittany Cody +11 more

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

The Lancet Oncology(2020)10.1016/s1470-2045(20)30475-7

N/A

0DataRank · unranked

125 citations

Vassiliki A. Papadimitrakopoulou, Katherine Minichiello, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +21 more

What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231198446

N/A

0DataRank · unranked

7 citations

Jacobi Hines, Valter Torri, Luca Porcu, Jessica Donington, Christine M. Bestvina +5 more

New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach

Annals of Translational Medicine(2023)10.21037/atm-22-2160

N/A

0DataRank · unranked

3 citations

Jcm Ho, Aya El Helali, Everett E. Vokes, Xiaofei Wang, Herbert Pang +1 more

Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

(2023)10.1158/1078-0432.c.6517530

N/A

0DataRank · unranked

0 citations

Rajani Kanteti, Jonathan S. Duke‐Cohan, Sivakumar Loganathan, Wanqing Liu, Caswell Patrick +16 more

Data from Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

(2023)10.1158/1078-0432.c.6517530.v1

N/A

0DataRank · unranked

0 citations

Rajani Kanteti, Jonathan S. Duke‐Cohan, Sivakumar Loganathan, Wanqing Liu, Caswell Patrick +16 more

Data from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

(2023)10.1158/1078-0432.c.6532910.v1

Top 100%

0DataRank

Top 100%0 citations

D. Neil Hayes, Theodore Karrison, Olivier Harismendy, José M. Flores, Tara Moore‐Medlin +17 more

Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation Trials

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.373

N/A

0DataRank · unranked

0 citations

David Huang, J. Hara, Ari J. Rosenberg, M. Arshad, Alexander T. Pearson +8 more

Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3206

N/A

0DataRank · unranked

57 citations

Kaiting Yang, Liangliang Wang, Jiaai Wang, Xiaona Huang, András Piffkó +12 more

Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance

Cancer(2024)10.1002/cncr.35663

N/A

0DataRank · unranked

3 citations

Briant Fruth, Andreas Rimner, Saiama N. Waqar, M. Mix, W. Jeffrey Petty +5 more

Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive CYP2D6 Genotyping in Cancer Palliative Care

Journal of Pain Research(2024)10.2147/jpr.s488416

N/A

0DataRank · unranked

2 citations

Theodore Karrison, Matthew Jack, Anish Choksi, Randall W. Knoebel, Kiang-Teck J Yeo +6 more

PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands

Journal of Experimental & Clinical Cancer Research(2025)10.1186/s13046-024-03270-x

N/A

0DataRank · unranked

9 citations

Alka Singh, Michael Korzinkin, Xiangying Cheng, Claudia Wing, Viktoria A. Sarkisova +23 more

Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas

Oral Oncology(2025)10.1016/j.oraloncology.2025.107207

N/A

0DataRank · unranked

9 citations

Anna Trzcinska, Frank Wen, Frederick M. Howard, James M. Dolezal, Emma Dyer +19 more

Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA

Oral Oncology(2025)10.1016/j.oraloncology.2025.107445

N/A

0DataRank · unranked

8 citations

Anna Starus, David H. Murray, Kirsten A. Keyser, Oliver Schauer, Simon Guellert +16 more

Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.06.025

N/A

0DataRank · unranked

53 citations

Xiaofei Wang, Lin Gu, Stephanie Q. Duong, Thomas E. Stinchcombe, Robert A. Kratzke +4 more

Impact of First‐of‐Its‐Kind Patient‐Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3747

N/A

0DataRank · unranked

0 citations

Sami Elahi, Matthew Jack, John Campbell, Emily Smith, Randall W. Knoebel +11 more

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9077

N/A

0DataRank · unranked

31 citations

Sumithra J. Mandrekar, Geoffrey R. Oxnard, David Kozono, Shauna L. Hillman, Suzanne E. Dahlberg +13 more

Everett E. Vokes

Indexed papers

Top data-sharing exemplar

Papers